Fadini, Gian Paolo
Buzzetti, Raffaella
Nicolucci, Antonio http://orcid.org/0000-0002-5939-6850
Larosa, Monica
Rossi, Maria Chiara
Cucinotta, Domenico
Enrico, Gabellieri
Alberto, Marangoni
Uberto, Pagotto
Claudio, Bongiorno
Concetta, Gatta
Andrea, Del Buono
Olga, Lamacchia
Pasquale, Maiellaro
Daniela, Antenucci
Gabriele, Brandoni
Francesca, Borroni
Giovanna, Gregori
Antonino, Di Benedetto
Giuseppe, Placentino
Franco, Cavalot
Cristina, Barale
Paolo, Fadini Gian
Paola, Del Sindaco
Chiara, Di Loreto
Roberto, Anichini
Giuseppe, Citro
Paola, D’Angelo
Silvia, Carletti
Raffaella, Buzzetti
Sara, Sterpetti
Mignogna, Carmen
Paolo, Elli
,
Funding for this research was provided by:
The study was funded by Sanofi S.r.l., Milan, Italy.
Article History
Received: 22 March 2022
Accepted: 15 June 2022
First Online: 21 July 2022
Declarations
:
: GPF has received consultancy of lecture fees from Abbott, AstraZeneca, Boehringer, Lilly, MSC, NovoNordisk, Mundipharma, Sanofi, Servier and Takeda. RB has received consultancy of lecture fees from Abbott, AstraZeneca, Lilly, NovoNordisk, Mundipharma and Sanofi. ML is an employee of Sanofi and may hold shares and/or stock options in the company. MCR and AN have received funding for research from Sanofi, NovoNordisk, Alfasigma, Artsana, AstraZeneca, Johnson&Johnson, Medtronic, Shionogi, SOBI, Meteda and Theras. DC has received consultation fees and speaker honoraria from Eli Lilly, Novo Nordisk, Roche Diagnostics, Sanofi and Takeda.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. The study protocol was approved by all local ethics committees of the participating centers.
: Informed consent was obtained from all patients for being included in the study.